Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
Sugauchi F, Orito E, Ohno T, Tanaka Y, Ozasa A, Kang JH, Toyoda J, Kuramitsu T, Suzuki K, Tanaka E, Akahane Y, Ichida T, Izumi N, Inoue K, Hoshino H, Iino S, Yotsuyanagi H, Kakumu S, Tomita E, Okanoue T, Nishiguchi S, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sata M, Miyakawa Y, Ueda R, Mizokami M. Sugauchi F, et al. Among authors: okanoue t. Hepatol Res. 2006 Oct;36(2):107-14. doi: 10.1016/j.hepres.2006.06.001. Epub 2006 Sep 7. Hepatol Res. 2006. PMID: 16956789
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.
Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N. Kasahara A, et al. Among authors: okanoue t. J Viral Hepat. 2004 Mar;11(2):148-56. doi: 10.1046/j.1365-2893.2003.00481.x. J Viral Hepat. 2004. PMID: 14996350
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyanagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K. Yano M, et al. Among authors: okanoue t. J Gastroenterol. 2004 Jun;39(6):570-4. doi: 10.1007/s00535-003-1344-z. J Gastroenterol. 2004. PMID: 15235875 Clinical Trial.
Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response.
Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N. Imai Y, et al. Among authors: okanoue t. J Gastroenterol. 2004 Nov;39(11):1069-77. doi: 10.1007/s00535-004-1448-0. J Gastroenterol. 2004. PMID: 15580400
Hepatitis B virus genotype G is an extremely rare genotype in Japan.
Kato H, Sugauchi F, Ozasa A, Kato T, Tanaka Y, Sakugawa H, Sata M, Hino K, Onji M, Okanoue T, Tanaka E, Kawata S, Suzuki K, Hige S, Ohno T, Orito E, Ueda R, Mizokami M. Kato H, et al. Among authors: okanoue t. Hepatol Res. 2004 Dec;30(4):199-203. doi: 10.1016/j.hepres.2004.09.004. Hepatol Res. 2004. PMID: 15589126
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
Tanaka E, Matsumoto A, Suzuki F, Kobayashi M, Mizokami M, Tanaka Y, Okanoue T, Minami M, Chayama K, Imamura M, Yatsuhashi H, Nagaoka S, Yotsuyanagi H, Kawata S, Kimura T, Maki N, Iino S, Kiyosawa K; HBV Core-Related Antigen Study Group. Tanaka E, et al. Among authors: okanoue t. Liver Int. 2006 Feb;26(1):90-6. doi: 10.1111/j.1478-3231.2005.01200.x. Liver Int. 2006. PMID: 16420514
479 results